# Dialab ZJG biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dialab-zjg-biotech-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Total disclosed funding: $14M
- Latest round: Series A (Sep 15, 2023)
- Investors on record: 5

## About

Based in Jiangsu, China, and founded in 2016, Dialab ZJG biotech Co., Ltd. is a medical equipment company that provides laboratory testing products. It has R&D centers in Shanghai and Jiangsu. In September 2023, Dialab ZJG biotech Co., Ltd. raised approximately CNY 100 million in series A funding led by new investor Grand Yangtze Capital, with participation from other new investors Shulan Junjie Capital, Suzhou Zhuopu Fund Management, Zhangjiagang Jolmo Investment Development, and Zhangjiagang Zhihui Venture Capital. It has obtained more than 40 chemiluminescent product registration certificates.

The company is engaged in providing laboratory testing products that assist in the diagnosis, etiology, and pathogenesis of difficult-to-identify and differentiate diseases. The team develops technologies for the expression and purification of transmembrane receptor proteins, ion channel proteins, and small molecule transmembrane transporter proteins involved in neural signaling pathways. The highly sensitive neurological disease detection system under development can be used for early diagnosis and efficacy monitoring of neurological autoimmune diseases, cerebrovascular diseases, neurological trauma, and neurodegenerative diseases.

In 2016, the company's net profit was CNY -367,000.

## Funding rounds

- Series A, Sep 15, 2023, $14M — Grand Yangtze Capital, Shulan Junjie Capital, Zhangjiagang Jolmo Investment Development, Zhangjiagang Zhihui Venture Capital, Suzhou Zhuopu Fund Management

## Investors

- Grand Yangtze Capital (https://capitalatlas.ai/funds/grand-yangtze-capital) — Series A
- Shulan Junjie Capital (https://capitalatlas.ai/funds/shulan-junjie-capital) — Series A
- Zhangjiagang Jolmo Investment Development — Series A
- Zhangjiagang Zhihui Venture Capital — Series A
- Suzhou Zhuopu Fund Management — Series A